REFERENCES
- Goldstein B H. Temporomandibular disorders: A review of current understanding. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 379–385
- Sessle B J. Masticatory muscle disorders: Basic science perspectives. Temporomandibular Disorders and Related Pain Conditions, Progress in Pain Research and Management, Vol. 4, P S Bryant, R A Dionne. IASP Press, Seattle 1995; 47–61
- Aghabeigi B, Haque M, Wasil S J, Hodges S J, Henderson B, Harris M. The role of oxygen free radicals in idiopathic facial pain. Br J Oral Maxillofac Surg 1997; 35: 161–165
- Zardeneta G, Milam S B, Schmitz J P. Iron-dependent generation of free radicals: Plausible mechanisms in the progressive deterioration of the temporomandibular joint. J Oral Maxillofac Surg 2000; 58: 302–308
- Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yildizhan H. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: Etiologic and therapeutic concerns. Rheumatol Int 2000; 26: 598–603
- Bagis S, Tamer L, Sahin G, Bilgin R, Guler H, Ercan B, et al. Free radicals and antioxidants in primary fibromyalgia: An oxidative stress disorder?. Rheumatol Int 2005; 25: 188–190
- Viggiano A, Monda M, Viggiano A, Viggiano D, Viggiano E, Chiefari M, et al. Trigeminal pain transmission requires reactive oxygen species production. Brain Res 2005; 1050: 72–78
- Vecchiet J, Cipollone F, Falasca K, Mezzetti A, Pizzigallo E, Bucciarelli T, et al. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett 2003; 335: 151–154
- Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277–285
- Isik A, Koca S S, Ustundag B, Celik H, Yildirim A. Paraoxonase and arylesterase levels in rheumatoid arthritis. Clin Rheumatol 2007; 26: 342–348
- Dworkin S F, LeResche L. Research diagnostic criteria for temporomandibular disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992; 6: 301–305
- Ellman G L. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70–77
- Hu M L, Louie S, Cross C E, Motchnik P, Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 1993; 121: 257–262
- La Du B N, Eckerson H W. The polymorphic paraoxonase/arylesterase isozymes of human serum. Fed Proc 1984; 43: 2338–2341
- Erel O. Automated measurement of serum ferroxidase activity. Clin Chem 1998; 44: 2313–2319
- Cai H X, Luo J M, Long X, Li X D, Cheng Y. Free-radical oxidation and superoxide dismutase activity in synovial fluid of patients with temporomandibular disorders. J Orofac Pain 2006; 20: 53–58
- Lee M C, Kawai Y, Shoji H, Yoshino F, Miyazaki H, Kato H, et al. Evidence of reactive oxygen species generation in synovial fluid from patients with temporomandibular disease by electron spin resonance spectroscopy. Redox Rep 2004; 9: 331–336
- Dworkin S F, Huggins K H, LeResche L, Von Korff M, Howard J, Truelove E, et al. Epidemiology of signs and symptoms in temporomandibular disorders: Clinical signs in cases and controls. J Am Dent Assoc 1990; 120: 273–281
- Nordahl S, Alstergren P, Kopp S. Tumor necrosis factor-alpha in synovial fluid and plasma from patients with chronic connective tissue disease and its relation to temporomandibular joint pain. J Oral Maxillofac Surg 2000; 58: 525–530
- Seresa I, Paragha G, Descheneb E, Fulop T, Jr., Khalil A. Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol 2004; 39: 59–66